TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association

Science Signaling

Volumn 5, Issue 222, 2012, Pages

  Xu, Pinglong ^a   Liu, Jianming ^a   Sakaki Yumoto, Masayo ^a   Derynck, Rik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOMER; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; ADAM PROTEIN; TIMP3 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; ANIMAL; CHO CELL; CRICETULUS; GENETICS; HAMSTER; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

ADAM PROTEINS; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; ENZYME ACTIVATION; HUMANS; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84860714018     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2002689     Document Type: Article

References (59)

1. C. P. Blobel, ADAMs: Key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6, 32-43 (2005).
2. D. F. Seals, S. A. Courtneidge, The ADAMs family of metalloproteases: Multidomain proteins with multiple functions. Genes Dev. 17, 7-30 (2003).
3. A. P. Huovila, A. J. Turner, M. Pelto-Huikko, I. Kärkkäinen, R. M. Ortiz, Shedding light on ADAM metalloproteinases. Trends Biochem. Sci. 30, 413-422 (2005).
4. G. Murphy, The ADAMs: Signalling scissors in the tumour microenvironment. Nat. Rev. Cancer 8, 929-941 (2008).
5. J. Pruessmeyer, A. Ludwig, The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Semin. Cell Dev. Biol. 20, 164-174 (2009).
6. M. Borrell-Pages, F. Rojo, J. Albanell, J. Baselga, J. Arribas, TACE is required for the activation of the EGFR by TGF-α in tumors. EMBO J. 22, 1114-1124 (2003).
7. B. B. Zhou, M. Peyton, B. He, C. Liu, L. Girard, E. Caudler, Y. Lo, F. Baribaud, I. Mikami, N. Reguart, G. Yang, Y. Li, W. Yao, K. Vaddi, A. F. Gazdar, S. M. Friedman, D. M. Jablons, R. C. Newton, J. S. Fridman, J. D. Minna, P. A. Scherle, Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 10, 39-50 (2006).
8. P. A. Kenny, M. J. Bissell, Targeting TACE-dependent EGFR ligand shedding in breast cancer. J. Clin. Invest. 117, 337-345 (2007).
9. A. Chalaris, N. Adam, C. Sina, P. Rosenstiel, J. Lehmann-Koch, P. Schirmacher, D. Hartmann, J. Cichy, O. Gavrilova, S. Schreiber, T. Jostock, V. Matthews, R. Häsler, C. Becker, M. F. Neurath, K. Reiss, P. Saftig, J. Scheller, S. Rose-John, Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J. Exp. Med. 207, 1617-1624 (2010).
10. P. Xu, R. Derynck, Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol. Cell 37, 551-566 (2010).
11. C. Liu, P. Xu, S. Lamouille, J. Xu, R. Derynck, TACE-mediated ectodomain shedding of the type I TGF-β receptor downregulates TGF-β signaling. Mol. Cell 35, 26-36 (2009).
12. U. Sahin, G. Weskamp, K. Kelly, H. M. Zhou, S. Higashiyama, J. Peschon, D. Hartmann, P. Saftig, C. P. Blobel, Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164, 769-779 (2004).
13. K. Horiuchi, S. Le Gall, M. Schulte, T. Yamaguchi, K. Reiss, G. Murphy, Y. Toyama, D. Hartmann, P. Saftig, C. P. Blobel, Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol. Biol. Cell 18, 176-188 (2007).
14. S. Mochizuki, Y. Okada, ADAMs in cancer cell proliferation and progression. Cancer Sci. 98, 621-628 (2007).
15. I. R. Patel, M. G. Attur, R. N. Patel, S. A. Stuchin, R. A. Abagyan, S. B. Abramson, A. R. Amin, TNF-α convertase enzyme from human arthritis-affected cartilage: Isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-α. J. Immunol. 160, 4570-4579 (1998).
16. A. L. Colón, L. A. Menchén, O. Hurtado, J. De Cristóbal, I. Lizasoain, J. C. Leza, P. Lorenzo, M. A. Moro, Implication of TNF-α convertase (TACE/ADAM17) in inducible nitric oxide synthase expression and inflammation in an experimental model of colitis. Cytokine 16, 220-226 (2001).
17. A. Amour, P. M. Slocombe, A.Webster, M. Butler, C. G. Knight, B. J. Smith, P. E. Stephens, C. Shelley, M. Hutton, V. Knäuper, A. J. Docherty, G. Murphy, TNF-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435, 39-44 (1998).
18. -/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat. Genet. 36, 969-977 (2004).
19. M. Federici, M. L. Hribal, R. Menghini, H. Kanno, V. Marchetti, O. Porzio, S.W. Sunnarborg, S. Rizza, M. Serino, V. Cunsolo, D. Lauro, A. Mauriello, D. S. Smookler, P. Sbraccia, G. Sesti, D. C. Lee, R. Khokha, D. Accili, R. Lauro, Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-α. J. Clin. Invest. 115, 3494-3505 (2005).
20. J. Schlöndorff, J. D. Becherer, C. P. Blobel, Intracellular maturation and localization of the tumour necrosis factor α convertase (TACE). Biochem. J. 347 (Pt. 1), 131-138 (2000).
21. F. Peiretti, M. Canault, P. Deprez-Beauclair, V. Berthet, B. Bonardo, I. Juhan-Vague, G. Nalbone, Intracellular maturation and transport of tumor necrosis factor α converting enzyme. Exp. Cell Res. 285, 278-285 (2003).
22. S. M. Le Gall, T. Maretzky, P. D. Issuree, X. D. Niu, K. Reiss, P. Saftig, R. Khokha, D. Lundell, C. P. Blobel, ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J. Cell Sci. 123, 3913-3922 (2010).
23. E. Díaz-Rodríguez, J. C. Montero, A. Esparís-Ogando, L. Yuste, A. Pandiella, Extracellular signal-regulated kinase phosphorylates tumor necrosis factor α-converting enzyme at threonine 735: A potential role in regulated shedding. Mol. Biol. Cell 13, 2031-2044 (2002).
24. H. Fan, C. W. Turck, R. Derynck, Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-α converting enzyme and of an alternatively translated polypeptide. J. Biol. Chem. 278, 18617-18627 (2003).
25. S. M. Soond, B. Everson, D. W. Riches, G. Murphy, ERK-mediated phosphorylation of Thr735 in TNFa-converting enzyme and its potential role in TACE protein trafficking. J. Cell Sci. 118, 2371-2380 (2005).
26. D. J. Killock, A. Ivetiæ, The cytoplasmic domains of TNFα-converting enzyme (TACE/ ADAM17) and L-selectin are regulated differently by p38 MAPK and PKC to promote ectodomain shedding. Biochem. J. 428, 293-304 (2010).
27. S. H. Willems, C. J. Tape, P. L. Stanley, N. A. Taylor, I. G. Mills, D. E. Neal, J. McCafferty, G. Murphy, Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem. J. 428, 439-450 (2010).
28. M. Wisniewska, P. Goettig, K. Maskos, E. Belouski, D. Winters, R. Hecht, R. Black, W. Bode, Structural determinants of the ADAM inhibition by TIMP-3: Crystal structure of the TACE-N-TIMP-3 complex. J. Mol. Biol. 381, 1307-1319 (2008).
29. J. Guinea-Viniegra, R. Zenz, H. Scheuch, D. Hnisz, M. Holcmann, L. Bakiri, H. B. Schonthaler, M. Sibilia, E. F. Wagner, TNFα shedding and epidermal inflammation are controlled by Jun proteins. Genes Dev. 23, 2663-2674 (2009).
30. Y. Itoh, A. Takamura, N. Ito, Y. Maru, H. Sato, N. Suenaga, T. Aoki, M. Seiki, Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J. 20, 4782-4793 (2001).
31. M. W. Olson, M. M. Bernardo, M. Pietila, D. C. Gervasi, M. Toth, L. P. Kotra, I. Massova, S. Mobashery, R. Fridman, Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1. J. Biol. Chem. 275, 2661-2668 (2000).
32. K. Brew, H. Nagase, The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity. Biochim. Biophys. Acta 1803, 55-71 (2010).
33. A. Sorokin, M. A. Lemmon, A. Ullrich, J. Schlessinger, Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond. J. Biol. Chem. 269, 9752-9759 (1994).
34. C. L. Burke, D. F. Stern, Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface. Mol. Cell. Biol. 18, 5371-5379 (1998).
35. B. D. Galvin, K. C. Hart, A. N. Meyer, M. K. Webster, D. J. Donoghue, Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR) 2 and FGFR2/Neu chimeras. Proc. Natl. Acad. Sci. U.S.A. 93, 7894-7899 (1996).
36. G. Jiang, J. den Hertog, J. Su, J. Noel, J. Sap, T. Hunter, Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-α. Nature 401, 606-610 (1999).
37. R. Majeti, Z. Xu, T. G. Parslow, J. L. Olson, D. I. Daikh, N. Killeen, A. Weiss, An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103, 1059-1070 (2000).
38. P. M. Siegel, W. J. Muller, Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation. Proc. Natl. Acad. Sci. U.S.A. 93, 8878-8883 (1996).
39. H. Fan, R. Derynck, Ectodomain shedding of TGF-α and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J. 18, 6962-6972 (1999).
40. S. Lammich, E. Kojro, R. Postina, S. Gilbert, R. Pfeiffer, M. Jasionowski, C. Haass, F. Fahrenholz, Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U.S.A. 96, 3922-3927 (1999).
41. T. S. Bringman, P. B. Lindquist, R. Derynck, Different transforming growth factor-α species are derived from a glycosylated and palmitoylated transmembrane precursor. Cell 48, 429-440 (1987).
42. X. Li, H. Fan, Loss of ectodomain shedding due to mutations in the metalloprotease and cysteine-rich/disintegrin domains of the tumor necrosis factor-α converting enzyme (TACE). J. Biol. Chem. 279, 27365-27375 (2004).
43. A. Murthy, V. Defamie, D. S. Smookler, M. A. Di Grappa, K. Horiuchi, M. Federici, M. Sibilia, C. P. Blobel, R. Khokha, Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. J. Clin. Invest. 120, 2731-2744 (2010).
44. W. B. Saunders, B. L. Bohnsack, J. B. Faske, N. J. Anthis, K. J. Bayless, K. K. Hirschi, G. E. Davis, Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J. Cell Biol. 175, 179-191 (2006).
45. E. Louis, C. Ribbens, A. Godon, D. Franchimont, D. De Groote, N. Hardy, J. Boniver, J. Belaiche, M. Malaise, Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin. Exp. Immunol. 120, 241-246 (2000).
46. T. Miyazaki, H. Kato, M. Nakajima, A. Faried, J. Takita, M. Sohda, Y. Fukai, S. Yamaguchi, N. Masuda, R. Manda, M. Fukuchi, H. Ojima, K. Tsukada, H. Kuwano, An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma. Br. J. Cancer 91, 1556-1560 (2004).
47. E. Mylona, C. Magkou, I. Giannopoulou, G. Agrogiannis, S. Markaki, A. Keramopoulos, L. Nakopoulou, Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: Relation to tumor phenotype and clinical outcome. Breast Cancer Res. 8, R57 (2006).
48. C. L. Sampieri, R. K. Nuttall, D. A. Young, D. Goldspink, I. M. Clark, D. R. Edwards, Activation of p38 and JNK MAPK pathways abrogates requirement for new protein synthesis for phorbol ester mediated induction of select MMP and TIMP genes. Matrix Biol. 27, 128-138 (2008).
49. P. Osenkowski, M. Toth, R. Fridman, Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J. Cell. Physiol. 200, 2- 10 (2004).
50. Y. Itoh, N. Ito, H. Nagase, R. D. Evans, S. A. Bird, M. Seiki, Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP. Mol. Biol. Cell 17, 5390-5399 (2006).
51. P. Reddy, J. L. Slack, R. Davis, D. P. Cerretti, C. J. Kozlosky, R. A. Blanton, D. Shows, J. J. Peschon, R. A. Black, Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme. J. Biol. Chem. 275, 14608-14614 (2000).
52. Q. Zhang, S. M. Thomas, V. W. Lui, S. Xi, J. M. Siegfried, H. Fan, T. E. Smithgall, G. B. Mills, J. R. Grandis, Phosphorylation of TNF-a converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. Proc. Natl. Acad. Sci. U.S.A. 103, 6901-6906 (2006).
53. Y. Zheng, J. Schlondorff, C. P. Blobel, Evidence for regulation of the tumor necrosis factor α-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J. Biol. Chem. 277, 42463-42470 (2002).
54. A. A. Pioszak, K. G. Harikumar, N. R. Parker, L. J. Miller, H. E. Xu, Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation. J. Biol. Chem. 285, 12435-12444 (2010).
55. L. Almeida-Souza, S. Goethals, V. de Winter, I. Dierick, R. Gallardo, J. Van Durme, J. Irobi, J. Gettemans, F. Rousseau, J. Schymkowitz, V. Timmerman, S. Janssens, Increased monomerization of mutant HSPB1 leads to protein hyperactivity in Charcot-Marie-Tooth neuropathy. J. Biol. Chem. 285, 12778-12786 (2010).
56. E. Or, A. Navon, T. Rapoport, Dissociation of the dimeric SecA ATPase during protein translocation across the bacterial membrane. EMBO J. 21, 4470-4479 (2002).
57. A. Bertolotti, Y. Zhang, L. M. Hendershot, H. P. Harding, D. Ron, Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2, 326-332 (2000).
58. D. R. McIlwain, P. A. Lang, T. Maretzky, K. Hamada, K. Ohishi, S. K. Maney, T. Berger, A. Murthy, G. Duncan, H. C. Xu, K. S. Lang, D. Häussinger, A. Wakeham, A. Itie-Youten, R. Khokha, P. S. Ohashi, C. P. Blobel, T. W. Mak, iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 335, 229- 232 (2012).
59. C. Adrain, M. Zettl, Y. Christova, N. Taylor, M. Freeman, Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335, 225-228 (2012).